US signs $1bn order for GSK, Vir’s COVID-19 antibodyThe US has made a sizeable order for GlaxoSmithKline and Vir Biotechnology’s antibody-based COVID-19 treatment sotrovimab said to Share XUS signs $1bn order for GSK, Vir’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-signs-1bn-order-for-gsk-virs-covid-19-antibody/
COVID antibodies from Roche, Celltrion backed for approval in EUThe EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, Share XCOVID antibodies from Roche, Celltrion backed for approval in EUhttps://pharmaphorum.com/news/first-covid-antibodies-from-roche-celltrion-backed-in-eu/
One dose of Regeneron’s COVID antibody protects for eight monthsA single dose of the COVID-19 monoclonal antibody therapy developing Regeneron reduced the risk of contracting the virus Share XOne dose of Regeneron’s COVID antibody protects for eight monthshttps://pharmaphorum.com/news/one-dose-of-regenerons-covid-antibody-protects-for-eight-months/
GSK side-lines COVID drug otilimab to focus on XevudyGlaxoSmithKline said today it would halt further development of its antibody for severe COVID-19 pneumonia – otilimab – Share XGSK side-lines COVID drug otilimab to focus on Xevudyhttps://pharmaphorum.com/news/gsk-side-lines-covid-drug-otilimab-to-focus-on-xevudy/
AZ files for emergency use of COVID-19 antibody combo in USAstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent Share XAZ files for emergency use of COVID-19 antibody combo in UShttps://pharmaphorum.com/news/az-files-for-emergency-use-of-covid-antibody-combo-in-us/
Novartis’ transplant drug hope iscalimab flunks mid-stage trialNovartis hopes of improving on tacrolimus as the standard drug for preventing organ rejection in transplant patients have Share XNovartis’ transplant drug hope iscalimab flunks mid-stage trialhttps://pharmaphorum.com/news/novartis-transplant-drug-hope-iscalimab-flunks-mid-stage-trial/
AC Immune claims half a win for tau drug in Alzheimer’s trialShares in AC Immune leaped today after the company said its tau-targeting Alzheimer’s disease candidate semorinemab hit one Share XAC Immune claims half a win for tau drug in Alzheimer’s trialhttps://pharmaphorum.com/news/ac-immune-claims-half-a-win-for-tau-drug-in-alzheimers-trial/
PROVENT trial puts AZ COVID antibody combo back on trackAstraZeneca’s AZD7442 has shown that it can prevent COVID-19 infection when given to healthy patients – the first Share XPROVENT trial puts AZ COVID antibody combo back on trackhttps://pharmaphorum.com/news/provent-trial-puts-az-covid-antibody-combo-back-on-track/
More malaria hope as NIH antibody protects against infectionA single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH) Share XMore malaria hope as NIH antibody protects against infectionhttps://pharmaphorum.com/news/more-malaria-hope-as-antibody-protects-against-infection/
